Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Randhawa Simrat sold 23,124 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Randhawa Simrat (EVP, Head of R&D) sold 23,124 Dianthus Therapeutics, Inc. shares at an average US$106.41 for US$2.46M under a trading plan, leaving 4,000 shares. Filed Sep 3, 2026 (Form 4).
- Sold
- 23,124 shares
- Price
- US$106.41 average (US$105.19 to US$106.74)
- Value
- US$2.46M
- Holding after
- 4,000 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Head of R&D
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Option exercise | 7,500 | US$17.88 | 11,500 | Direct |
| Sep 1, 2026 | Common Stock | Option exercise | 6,249 | US$21.77 | 17,749 | Direct |
| Sep 1, 2026 | Common Stock | Option exercise | 9,375 | US$22.07 | 27,124 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 2,600 | US$105.19 | 24,524 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 7,215 | US$106.25 | 17,309 | Direct |
| Sep 1, 2026 | Common Stock | Sale | 13,309 | US$106.74 | 4,000 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Randhawa Simrat
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Randhawa Simrat · Jun 2, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Form 4 · Veness Adam M · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026